Bionovate Technologies Corp (BIIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Bionovate Technologies Market Cap
Bionovate Technologies has a market cap or net worth of $775.00 as of August 18, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
775.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 12, 2014, Bionovate Technologies's market cap has decreased from 805.25K to 775.00, a decrease of -99.90%. That is a compound annual growth rate of -46.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 775.00 | 9,587.50% |
| Dec 31, 2024 | 8.00 | -98.97% |
| Dec 30, 2022 | 775.00 | -99.93% |
| Dec 31, 2021 | 1.16M | -99.87% |
| Dec 31, 2020 | 866.92M | 159,577.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 362.70M |
| CytoDyn | 344.75M |